Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clinical Trials
Hoffmann-La Roche
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama; Mitchell Cancer Institute
Mobile, Alabama, United States
- Long Beach Memorial Medical Center; Oncology
Long Beach, California, United States
- Lac-Usc Medical Center
Los Angeles, California, United States
- Usc Norris Cancer Center
Los Angeles, California, United States
- Pacific Cancer Care - Monterey
Monterey, California, United States
- Sacramento Center for Hematolo
Sacramento, California, United States
- Pacific Cancer Care
Salinas, California, United States
- Kaiser Permanente - Franklin
Denver, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Florida Cancer Specialists - Fort Myers (colonial Center Dr)
Fort Myers, Florida, United States
- Florida Cancer Specialist, North Region
St. Petersburg, Florida, United States
- University Cancer & Blood Center, Llc
Athens, Georgia, United States
- Emory University Clinic
Atlanta, Georgia, United States
- Central Georgia Cancer Care Pc
Macon, Georgia, United States
- Summit Cancer Care Pc
Savannah, Georgia, United States
- Ingalls Memorial Hosp
Harvey, Illinois, United States
- Edward Cancer Center Naperville
Naperville, Illinois, United States
- Edward Cancer Center Plainfield
Plainfield, Illinois, United States
- University of Kentucky Medical Center
Lexington, Kentucky, United States
- Johns Hopkins Univ; Bunting Blaustein Cancer Center
Baltimore, Maryland, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- St. Joseph Mercy Hospital; Cancer Care Center.
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute..
Detroit, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Southeast Nebraska Cancer Center;; Southeast Nebraska Hematology and Oncology
Lincoln, Nebraska, United States
- Nebraska Methodist Hospital; Cancer Center
Omaha, Nebraska, United States
- Dartmouth Hitchcock Med Center
Lebanon, New Hampshire, United States
- Oncology Hematology Care Inc
Cincinnati, Ohio, United States
- University of Oklahoma; Stephenson Oklahoma Canc Ctr
Oklahoma City, Oklahoma, United States
- Milton S. Hershey Medical Center; Penn State Cancer Inst.
Hershey, Pennsylvania, United States
- Chattanooga Oncology and Hematology Associates, Pc
Chattanooga, Tennessee, United States
- West Clinic
Germantown, Tennessee, United States
- Sarah Cannon Cancer Center and Research Institute
Nashville, Tennessee, United States
- Ut Southwestern Mc at Dallas
Dallas, Texas, United States
- Ctr for Cancer and Blood Disorders
Fort Worth, Texas, United States
- Scott and White Hospital; Cancer Center
Temple, Texas, United States
- Virginia Cancer Institute
Richmond, Virginia, United States
- Seattle Cancer Care Alliance - Evergreen Health
Kirkland, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2013
- Primary completion
- 14 Mar 2016
- Completion
- 14 Mar 2016
- Last update posted
- 18 Sept 2017
- Registered enrollment
- 280
- Registry id
- NCT01765582
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.